VIVA BIOINNOVATOR

As the investment division of Viva Biotech, Viva BioInnovator is dedicated to investing globally in biotech innovation with novel solutions to unmet medical needs across multiple therapeutic areas, ranging from biopharmaceuticals to devices, diagnostics, and life science tools.

By leveraging Viva Biotech’s deep experience and technical advantages in novel drug R&D, Viva BioInnovator provides both cash and in-kind services, also called Equity-for-Services (EFS), for its investments.

In 2022, Viva BioInnovator gave its support to Domain Therapeutics and invested in the group to support its advancement to the clinic stage.